Cancer research (Chicago, Ill.), 2019-07-01, Vol.79 (13), p.3185-3191
Chemotherapeutic regimens for ovarian cancer often include the use of DNA interstrand crosslink-inducing agents (e.g., platinum drugs) or DNA double-strand break-inducing agents. Unfortunately, the majority of patients fail to maintain a durable response to treatment, in part, due to drug resistance, contributing to a poor survival rate. In this study, we report that cisplatin sensitivity can be restored in cisplatin-resistant ovarian cancer cells by targeting the chromatin-associated high-mobility group box 3 (HMGB3) protein. HMGB proteins have been implicated in the pathogenesis and prognosis of ovarian cancer, and HMGB3 is often upregulated in cancer cells, making it a potential selective target for therapeutic intervention. Depletion of HMGB3 in cisplatin-sensitive and cisplatin-resistant cells resulted in transcriptional downregulation of the kinases ATR and CHK1, which attenuated the ATR/CHK1/p-CHK1 DNA damage signaling pathway. HMGB3 was associated with the promoter regions of
, suggesting a new role for HMGB3 in transcriptional regulation. Furthermore, HMGB3 depletion significantly increased apoptosis in cisplatin-resistant A2780/CP70 cells after cisplatin treatment. Taken together, our results indicate that targeted depletion of HMGB3 attenuates cisplatin resistance in human ovarian cancer cells, increasing tumor cell sensitivity to platinum drugs. SIGNIFICANCE: This study shows that targeting HMGB3 is a potential therapeutic strategy to overcome chemoresistance in ovarian cancer.
RNA, Small Interfering - genetics ; Cell Proliferation ; HMGB3 Protein - antagonists & inhibitors ; Humans ; Ovarian Neoplasms - pathology ; Drug Resistance, Neoplasm ; Cisplatin - pharmacology ; HMGB3 Protein - genetics ; HMGB3 Protein - metabolism ; Female ; Antineoplastic Agents - pharmacology ; Ovarian Neoplasms - metabolism ; Tumor Cells, Cultured ; Ovarian Neoplasms - drug therapy ; Apoptosis ; HMGB3 ; DNA damage response ; ovarian cancer ; cisplatin resistance
HighWire Press (Free Journals)
Permalink to record